Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High prevalence of clonal hematopoiesis‐type genomic abnormalities in cell‐freeDNAin invasive gliomas after treatment

International Journal of Cancer(2021)10.1002/ijc.33481Source: DataRank Database

High prevalence of clonal hematopoiesis‐type genomic abnormalities in cell‐freeDNAin invasive gliomas after treatment is a research paper published in International Journal of Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.81)OA: hybridTopics (111)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

David Piccioni ORCID,Amélie Boichard ORCID,Suzanna Lee ORCID,Rebecca E. Jimenez,Jason K. Sicklick ORCID

Live enrichment

PubMed:33497479 PMC:PMC8048515 OpenAlex:https://openalex.org/W3125636797

Foundation for the National Institutes of Health

Grant: P30 CA023100

National Institutes of Health

Grant: 3P30CA023100-25S4

Specialized Cancer Center Support Grant

FWCI

1.81

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.33481

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.33481

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33481

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ijc.33481

journalhttps://doi.org/10.1002/ijc.33481

Fields of Study

Cancer Genomics and DiagnosticsGlioma Diagnosis and TreatmentAcute Myeloid Leukemia Research0302 clinical medicine03 medical and health sciences

MeSH Terms

Cell-Free Nucleic AcidsTemozolomideClonal HematopoiesisAdultAgedAged, 80 and overBrain NeoplasmsDNA, NeoplasmGliomaHumansMaleMiddle AgedMutationPrognosisSurvival AnalysisTreatment OutcomeSequence Analysis, DNAYoung AdultHigh-Throughput Nucleotide SequencingChemoradiotherapy

Keywords

GliomaInternal medicineCancerOncologyMedicineOdds ratioHazard ratioCell-free fetal DNATemozolomideCancer researchBiologyConfidence intervalGeneticsChGlioblastoma MultiformeMolecular ProfilingCell-free DnaLiquid BiopsyClonal HematopoiesisMaleClinical Research (rcdc)Molecular Cancer BiologyBrain Disorders (rcdc)Glioma (mesh)80 and over80 and over (mesh)Temozolomide (mesh)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Cancer (rcdc)Aged, 80 and overBrain Cancer (rcdc)Humans (mesh)Young Adult (mesh)Mutation (mesh)Brain NeoplasmsHigh-Throughput Nucleotide Sequencing (mesh)Treatment Outcome (mesh)High-Throughput Nucleotide SequencingChemoradiotherapyDNA, Neoplasmfree DNA1112 Oncology and Carcinogenesis (for)Middle AgedPrognosisTreatment OutcomeBrain Neoplasms (mesh)Neoplasm (mesh)Sequence AnalysisCell-Free Nucleic AcidsCell-Free Nucleic Acids (mesh)Chemoradiotherapy (mesh)AdultOncology and Carcinogenesis610cell&#8208Rare Diseases (rcdc)Young AdultRare DiseasesCancer GenomicsClinical ResearchMiddle Aged (mesh)3211 Oncology and carcinogenesis (for-2020)HumansOncology & CarcinogenesisAgedBiomedical and Clinical SciencesGenetics (rcdc)Aged (mesh)Human GenomeSurvival Analysis (mesh)Cancer (hrcs-hc)DNASequence Analysis, DNAClonal Hematopoiesis (mesh)Prognosis (mesh)Human Genome (rcdc)Survival AnalysisBrain DisordersBrain CancerOncology & Carcinogenesis (science-metrix)MutationAdult (mesh)NeoplasmDNA (mesh)Cancer Genomics (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: No poverty